Photobiomodulation therapy systems provide a highly effective way to treat many common ailments to the human body. Many embodiments described herein enable two or more light therapy devices to be communicatively coupled together in various ways. In some embodiments, the light therapy system includes a first light device and a second light device arranged and configured to be communicatively coupled to the first light device. Each of the light devices may include a housing, a communication module, and a plurality of lights arranged and configured to emit at least one of red light and near infrared light.

The present invention discloses a method for adjusting the level of galanin in brain, by optic nerve light conduction, comprising the following step: controlling light of different wavelengths, different intensities and different frequencies to illuminate an eye by a light adjustment device, so that galanin receptors in the eye are activated to produce signal, stimulation, and signals transmitted to the hypothalamic visual receiving area via the optic nerve can influence the level of galanin expression in the brain.

A head worn device for treating neurogenerative diseases. The head worn device has LEDs mounted to the device. Two printed circuit boards (PCB) are also mounted on the head worn device. Each PCB has a microprocessor and a battery in electrical communication. Each PCB controls a speaker for emitting audio and a vibrating device for emitting a vibration. The LEDs, speaker and vibrating device are in electrical communication with the microprocessor. The microprocessor is programmed to control the LEDs, the speaker and the vibrating device so that each operate at a regulated frequency so that generated light, sound and vibration travel to the user's brain for medical treatment.

A system for tracking tumors during radiotherapy for interleaving treatment pulses with imaging pulses is disclosed. The system includes a plurality of multisource scanning eBeam X-ray tubes, each having multiple focal spots. The X-ray tubes are configured to emit X-rays in a plurality of different locations on a target by sequentially emitting the X-rays to the focal spots in the different focal spots. This is done such that the X-rays can be emitted to the plurality of different locations without substantially moving the X-ray tube or the target. The system further includes multiple imager panels configured to act as targets and configured to receive the X-rays from the focal spots of the X-ray tube. The system further includes a tomosynthesis reconstruction module configured to process outputs from the imager panels to construct a unified three-dimensional image that takes information from each of the different imager panels.

This invention relates to a neoadjuvant therapy for bladder cancer in bladder cancer patients who are scheduled for a cystectomy and methods of carrying out such a neoadjuvant therapy. In particular, the invention relates to a composition comprising hexyl 5-ALA ester (HAL) or a pharmaceutically acceptable salt thereof for use in a neoadjuvant therapy for bladder cancer in a bladder cancer patient who is scheduled for a cystectomy, the therapy comprises instilling said composition into the bladder of said patient and exposing the inside of said bladder to light.

A medical device assembly is provided for removable insertion into a catheter with a lumen. The medical device assembly comprises an electromagnetic radiation (EMR) source for providing non-ultraviolet, therapeutic EMR having an intensity sufficient to inactivate one or more infectious agents and/or to stimulate healthy cell growth causing a healing effect, and a removable EMR conduction system at least partially insertable into and removable from the lumen of the catheter. The EMR conduction system has at least one optical element providing axial propagation of the therapeutic EMR through an insertable elongate body. The elongate body may have an exterior surface between a coupling end and a distal end tip that has at least one modified portion permitting the radial emission of therapeutic EMR from the elongate body proximate the modified portion. Such modified portion may be gradient along the exterior surface.

Photobiomodulation therapy systems provide a highly effective way to treat many common ailments to the human body. Many embodiments described herein enable two or more light therapy devices to be communicatively coupled together in various ways. In some embodiments, the light therapy system includes a first light device and a second light device arranged and configured to be communicatively coupled to the first light device. Each of the light devices may include a housing, a communication module, and a plurality of lights arranged and configured to emit at least one of red light and near infrared light.

A device that suppresses a pathological synchronous and oscillatory neuron activity, and includes a non-invasive stimulation unit implantable in a patient, for stimulation, using electrical and/or optical stimuli, of neurons in the patient's brain and/or spinal cord, where those neurons are showing pathologically synchronous and oscillatory neuron activity, and the stimuli are deigned to suppress are this activity when administered to the patient. Moreover, a measuring unit records measurement signals reflecting the neuron activity of the stimulated neurons and a control and analysis unit controls the stimulation unit to administer stimuli, check the success of stimulation based on the measurement, and, if the stimulation success is not sufficient, insert one or more stimulation breaks in the application of the stimuli or extend one or more stimulation breaks, where no stimuli that could suppress the pathological synchronous and oscillatory neuron activity are applied during the stimulation breaks.

A wireless, programmable stroboscopic eyewear device is used to clear amyloid proteins from the brain. The device employs passive, non-invasive stroboscopic lens technology to combat buildup of amyloid proteins in the brain by improving gamma oscillations in the brain. The wearable device delivers non-invasive stroboscopic stimulation in the 20-60 Hz range. Treatment sessions are for an average of twenty minutes a day, seven days a week through passive use. The wearable device transmits data to a smartphone based mobile application, as a means to encourage an effective treatment protocol as determined and monitored by the user's physicians and caregivers. The stroboscopic effect is created through the synchronized opening and closing of Liquid Crystal Display (LCD) lenses which electronically switch from clear to opaque, utilizing noninvasive ambient light to create the strobe effect, as opposed to invasive flashing lights.

A pet care device may include a removable or swappable care tool mounted on a head. The head may include a sterilizer and a sensor to determine what kind of care tool is mounted. A controller may identify the type of care tool mounted on the head based on a sensing value of the sensor and control the sterilizer based on the identified care tool.